efficacy paroxetine placebo treating anxiety depression meta-analysis change hamilton rating scales abstract background previous meta-analyses published unpublished trials antidepressants provide modest benefits compared placebo treatment depression argued benefits clinically significant meta-analyses based trials submitted initial fda approval medication limited aimed treating depression time assess efficacy selective serotonin reuptake inhibitor ssri treatment anxiety depression complete data set published unpublished trials sponsored manufacturer methods findings glaxosmithkline required post results sponsored clinical trials online providing opportunity assess efficacy ssri paroxetine complete data set trials conducted examined data placebo-controlled double-blind trials paroxetine included change scores hamilton rating scale anxiety hrsa and/or hamilton rating scale depression hrsd treatment anxiety num efficacy difference paroxetine placebo modest num independent baseline severity anxiety change placebo-treated individuals replicated num magnitude paroxetine response efficacy superior treatment panic disorder num generalized anxiety disorder num published trials showed significantly larger drug-placebo differences unpublished trials num num depression trials num benefit paroxetine placebo consistent previous meta-analyses antidepressant efficacy num conclusions empirical evidence paroxetine modest advantage placebo treatment anxiety depression treatment implications discussed 
